Sable Bio secures a £2.7m seed round led by MMC Ventures to improve drug safety assessment for pharma firms

Sable Bio builds AI tools to assess drug target safety in pharmaceutical research. Its platform analyses scientific data to identify potential toxicity risks earlier in development.